Cinemark Holdings, Inc. 2025 Q2 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2025, for Cinemark Holdings, Inc. ("Holdings") and its primary operating subsidiary, Cinemark USA, Inc. ("CUSA"). The company operates in the theatrical exhibition industry with 497 theaters and 5,647 screens across the U.S. and 13 Latin American countries. The filing includes unaudited condensed consolidated financial statements for both entities.
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Total Revenue | $940.5 million | $734.2 million | $1,481.2 million | $1,313.4 million |
| Operating Income | $173.5 million | $82.9 million | $154.3 million | $100.5 million |
| Net Income (Holdings) | $94.7 million | $46.6 million | $56.1 million | $71.9 million |
| Diluted EPS (Holdings) | $0.63 | $0.32 | $0.38 | $0.51 |
| Operating Cash Flow (YTD) | $156.8 million | $162.2 million | $156.8 million | $162.2 million |
| Capital Expenditures (YTD) | $52.2 million | $47.2 million | $52.2 million | $47.2 million |
| Cash and Equivalents (End of Period) | $931.6 million | $788.8 million | $931.6 million | $788.8 million |
| Total Debt (Carrying Value) | $2,360.5 million | $2,363.7 million | $2,360.5 million | $2,363.7 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 28.1% in Q2 2025 compared to Q2 2024, driven by a 27.7% increase in admissions revenue and a 29.0% increase in concession revenue. U.S. attendance rose 26.8% to 36.9 million patrons.
- Profitability: Operating income more than doubled to $173.5 million in Q2 2025 from $82.9 million in Q2 2024. Operating margin improved to 18.4% from 11.3%.
- Cost Structure: Film rentals and advertising costs increased 32.7% to $270.8 million, reflecting a higher concentration of high-grossing films. Salaries and wages rose 12.4% due to higher attendance and wage inflation.
- Impairment: The company recorded a $1.6 million impairment charge in Q2 2025 related to three international theaters, compared to no impairment in Q2 2024.
- Share Repurchases: In Q1 2025, the company completed a $200 million share repurchase program, reducing outstanding shares and impacting diluted EPS calculations.
Guidance, Outlook, and Risks
- Convertible Notes Settlement: On May 15, 2025, the company notified holders of its $460 million 4.50% Convertible Senior Notes (maturing August 2025) of its election to settle the principal in cash and any excess value in shares. Approximately 17.0 million shares are estimated to be issued for the excess value.
- Dividends: The Board reinstated the quarterly dividend at $0.08 per share in Q1 2025. Dividends of $10.1 million and $9.4 million were paid in Q1 and Q2 2025, respectively.
- Capital Expenditures: The company has signed commitments for 4 new theaters and 33 screens with an estimated remaining investment of $71.4 million, with $4.9 million expected in the remainder of 2025.
- Tax Legislation: The "One Big Beautiful Bill Act" (OBBBA) signed on July 4, 2025, may impact deferred tax assets and valuation allowances; the company is currently assessing the impact.
- Risks: Key risks include the volume and performance of new film content, competition from streaming, inflationary pressures on labor and concession costs, and foreign currency exchange fluctuations (notably in Argentina).
Investor Verification Checklist
- Convertible Note Settlement: Verify the final share count and cash outflow for the August 2025 settlement of the $460 million convertible notes.
- NCM Investment: Review the fair value adjustment of the National CineMedia, Inc. (NCMI) investment, which resulted in a $7.9 million net loss for the six months ended June 30, 2025.
- Debt Covenants: Confirm continued compliance with the Senior Secured Credit Facility covenants, specifically the Consolidated Net Total Leverage Ratio (1.41 to 1.00 as of June 30, 2025).
- International Currency: Monitor the impact of foreign currency fluctuations on international segment results, particularly the hyper-inflationary accounting for Argentina.
- Capital Allocation: Track the execution of the $71.4 million in remaining capital commitments for new theater builds and expansions.